By ARTES Biotechnology…
To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.
Subscribe to Supplier
Heterologous production of holoproteins in Hansenula polymorpha
Features of ARTES´ Hansenula polymorpha protein production platform
Hansenula polymorpha is a ubiquitous yeast species present in soil, water and on fruits. It is non-pathogenic to animals and humans, does not produce toxins and is an established platform for production of recombinant proteins. Examples of products marketed and produced in ARTES´ Hansenula expression platform are diversified in application. Clients products include e.g. HEPLISAV B by Dynavax, Germany and USA, HEPAVAX-Gene by Berna Biotech Korea Corp., Genevac-B by Serum Institute of India and the HBsAg component of multivalent vaccines (e.g. HEXYON resp HEXACIMA, Sanofi Pasteur, France), Insulin (Wockhardt Ltd., India), Interferon alpha2a and Hirudin (Minapharm Biogenetics, Egypt).
To learn more about Heterologous production of holoproteins in Hansenula polymorpha, please download White Paper: